|
2021
|
Invention
|
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-n-(2-(trifluorometh... |
|
2020
|
Invention
|
Crystals of aniline pyrimidine compound serving as egfr inhibitor.
The present application belon... |
|
2019
|
Invention
|
Solid pharmaceutical composition containing 1,3,5-triazine derivative or salt thereof. A solid ph... |
|
2018
|
Invention
|
Selective mcl-1 inhibitor and preparation and use thereof. The present invention provides a selec... |
|
|
Invention
|
Crystalline sulfamide compound. The present application relates to a crystalline sulfamide compou... |
|
|
Invention
|
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof... |
|
|
Invention
|
Urea compound as dual inhibitor of ido and tdo. Provided are a urea compound having a dual inhibi... |
|
|
Invention
|
1,3,5-triazine derivative salt, crystal, preparation method, pharmaceutical composition and use t... |
|
|
Invention
|
Anaplastic lymphoma kinase inhibitor and preparation method and use thereof. The present inventio... |
|
2017
|
Invention
|
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor.... |
|
|
Invention
|
Bcl-2 selective inhibitor and preparation and use thereof. A compound represented by formula (I) ... |
|
|
Invention
|
Crystal of salt of quinazoline derivative. Disclosed are a crystal of a maleate of a compound of ... |
|
|
Invention
|
Crystal of dpp-iv long-acting inhibitor and salt. The present application relates to a crystal of... |
|
|
Invention
|
Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as mek inhibitor. Pr... |
|
|
Invention
|
Crystal of dpp-iv long-acting inhibitor and salt thereof. The present application relates a cryst... |
|
|
Invention
|
Crystals of aniline pyrimidine compound serving as egfr inhibitor. The present application belong... |
|
|
Invention
|
Pyrrolopyrimidine crystal for preparing jak inhibitor. The present application relates to the fie... |
|
|
Invention
|
Preparation method for chiral pyrrolopyrimidine compound. Provided are a preparation method for a... |
|
|
Invention
|
Pyrrolopyrimidine comprising cyclopentyl substituent. A pyrrolopyrimidine comprising a cyclopenty... |
|
|
Invention
|
Substituted pyrrolopyrimidine cdk inhibitor, pharmaceutical composition containing same and use t... |
|
|
Invention
|
Iridinesulfonamide compound and use method thereof. An iridinesulfonamide compound having isocitr... |
|
|
Invention
|
Sultam compound and application method thereof. Provided are a sultam compound having isocitrate ... |
|
|
Invention
|
Tricyclic compound for bromodomain-containing protein inhibitor and preparation pharmaceutical co... |
|
2016
|
Invention
|
Kinase activity regulating compound intermediates preparation method.
The present application re... |
|
|
Invention
|
Crystals of thiadiazole derivative dpp-iv inhibitors and uses thereof. The present invention belo... |
|
|
Invention
|
1,3,5-triazine derivative and method of using same. Disclosed are compounds having formulae I and... |
|
|
Invention
|
Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal. The present invention disc... |
|
|
Invention
|
Antitumor compound targeting idh2 mutation and method of use thereof. The present application rel... |
|
|
Invention
|
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-oxo-2,3-dihydro-1h-benzo... |
|
|
Invention
|
Salts of quinazoline derivative and method for preparing the same. The present application relate... |
|
|
Invention
|
Substituted amino six-membered saturated heteroalicycles as long-acting dpp-iv inhibitors. The pr... |
|
2015
|
Invention
|
Pyrrolopyrimidine compound. The present application relates to the field of pharmaceutical chemis... |
